Lonza | LONN - Ebit


Lonza reported CHF673M in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Akzo Nobel EUR -73M 324M Sep/2026
Alcon AG USD 44M 253M Jun/2026
Almirall EUR 71.55M 41.32M Jun/2026
AstraZeneca USD 4.66B 1.5B Sep/2026
BASF EUR 188M 1.25B Sep/2026
Bayer EUR 129M 626M Sep/2026
Beiersdorf EUR 760M 256M Jun/2026
Covestro EUR -324M 5.72B Dec/2025
Demant DKK 2.12B 58M Jun/2026
Fresenius EUR 639M 80M Sep/2026
Fresenius Medical Care EUR 384M 96.55M Sep/2026
Geberit CHF 134.1M 65.8M Dec/2025
Genmab DKK 407M 221M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.86B 251M Sep/2026
GN Store Nord DKK 340M 282M Sep/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Johnson Matthey GBP 198M 56M Jun/2026
Merck EUR 660M 437M Sep/2026
Novartis USD 5.14B 411M Sep/2026
Philips EUR 206M 435M Sep/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 4.72B 3.6B Sep/2026
Sika AG CHF 724.9M 73.2M Dec/2025
Smith & Nephew USD 505M 65M Jun/2026
Solvay EUR 123M 52M Sep/2026
UCB EUR 1.29B 571M Dec/2025